In a landmark study spearheaded by a team of researchers from the Xiangya Hospital of Central South University in China, multidrug-resistant organisms (MDRO) infection rates were analysed in relation to the COVID-19 pandemic’s timeline. Split into three phases, the pre, during, and post-pandemic periods, the study utilized a post-hoc analysis approach, focusing on patients with infected pancreatic necrosis (IPN). The findings revealed a significant decrease in MDRO infection rates during the pandemic period compared to pre-pandemic levels, which surprisingly did not significantly differ from the post-pandemic period.
Further analysis showed that this could be linked to notably decreased prophylactic antimicrobial usage and shorter stays in the intensive care unit (ICU) during the pandemic. These findings suggest that strict infection prevention measures implemented during the COVID-19 pandemic could have had a positive impact, translating to reduced infection rates. Acute pancreatitis (AP), a common gastrointestinal disorder requiring hospitalization, has witnessed an increased incidence of infection caused by MDROs in patients with IPN. This factor contributes to adverse clinical outcomes and increased mortality rates among patients.
The pandemic has led to unexpected consequences in healthcare systems around the world. Contrary to widespread belief that inappropriate antibiotic usage during the pandemic has led to increasing antimicrobial resistance, stringent infection and prevention control (IPC) measures like enhanced hygiene protocols and widespread use of personal protective equipment (PPE) may have significantly reduced the transmission of MDROs. Understandably, several variables such as the capacity of individual healthcare systems, adherence to infection prevention measures, and the level of intervention adoption would impact the trends of antimicrobial resistance (AMR).
The researchers emphasised the unique opportunity the pandemic offered to observe key infection control practices, potentially informing long-term strategies for AMR mitigation. The research also underscored the potential role of strict IPC measures such as lockdowns in reducing MDRO transmission rates. This is particularly relevant to IPN patients who are more vulnerable to nosocomial MDRO transmission due to prolonged ICU stays, invasive interventions, and frequent antibiotic exposure.
Despite its significance, understanding the extent of the pandemic’s effect on MDRO incidence in IPN remains an ongoing process. The wealth of IPC best practices and data collected during the pandemic can undoubtedly guide future infection control strategies.